Join
Live feed
·
INSIDERFilingvia Quantisnow
Vir Biotechnology Inc. logo

EVP & Chief Technology Officer Hanly Ann M. sold $133,936 worth of shares (14,168 units at $9.45), decreasing direct ownership by 11% to 117,901 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
VIR· Vir Biotechnology Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VIR (Vir Biotechnology Inc.) and more on Quantisnow.